Hematology/Oncology News

Patients with metastatic gastrointestinal cancer may not need a 5-FU bolus as part of their treatment, according to retrospective study results.

The use of chatbot tools may be a valuable part of health management strategies to improve access to cancer genetic services, according to study results.

The melanoma 31-gene expression profile test can help physicians to better estimate risk for sentinel lymph nodes, possibly reducing the need for biopsies, according to a study.

CHICAGO — In this Healio video exclusive, Sandra Swain, MD, FACP, FASCO, discusses identifying and finding your passion as a woman in medicine and the importance of uplifting young women researchers.

In this edition, FDA approves Rybrevant for advanced lung cancer, screening orders in eligible patients higher with digital health program and more.

In this episode, host Shikha Jain, MD, speaks with Amita Patnaik, MD, FRCPC, about providing patient access to breakthrough drug developments, bringing early phase cancer trials to physicians and more.

Five-fraction stereotactic body radiotherapy proved noninferior to conventional radiotherapy with regard to biochemical or clinical failure for men with localized prostate cancer, according to randomized phase 3 study results.

Concurrent administration of chemoradiation and immunotherapy did not improve survival for patients with limited-stage small cell lung cancer, according to a study presented at American Society for Radiation Oncology Annual Meeting.

Nivolumab plus chemotherapy significantly extended PFS for children and adults with newly diagnosed advanced Hodgkin lymphoma compared with standard of care, according to results of a randomized phase 3 trial.

An invitation to screen for Helicobacter pylori along with fecal immunochemical testing did not significantly reduce gastric cancer incidence or mortality over approximately 5 years vs. FIT alone, according to a study conducted in Taiwan.